Tesla's 2026 capital expenditure plan has reached at least $25 billion, with a significant portion directed toward scaling production of its Optimus humanoid robot, according to figures disclosed during the company's second-quarter 2026 earnings report1,2.
CEO Elon Musk described 2026 as a "massive" year for capital expenditures during the earnings call. The spending level appears to have unsettled investors: Tesla's stock dropped after the earnings release showed the company's cash flow had turned negative.
The Optimus push involves converting existing electric vehicle production lines to manufacture humanoid robots, a move the Motley Fool characterized as leaving the company with "no easy way to backtrack". Tesla has effectively gone all in on Musk's autonomous robotics vision, which also underpins the company's robotaxi program.
The capital commitment comes alongside a separate signal about Tesla's product portfolio: the company recently ended sales of its solar roof product, a reminder that not all of Musk's large-scale bets have translated into profitable businesses.
ANALYSIS The reallocation of EV production lines to Optimus manufacturing represents a concrete operational trade-off, not merely an incremental R&D expense. Tesla is displacing revenue-generating vehicle capacity to build robots that have yet to demonstrate commercial-scale demand, making the negative cash flow position a direct consequence of the strategic pivot rather than a temporary dip.
The $25 billion capital budget figure, combined with the production-line conversion, places Optimus among the most capital-intensive humanoid robotics programs disclosed by any company to date, though comparable figures from competitors are not available in the evidence.